Family summary
Current and historical shortage references are available across related Budesonide presentations from multiple manufacturers.
- 2 current shortage context pages.
- 8 historical shortage context pages.
- 4 manufacturers represented.
Budesonide - Drug Shortage Information
Public shortage context is available across 10 visible exact NDC pages for this generic family.
This family page is organized from FDA/openFDA shortage records and other publicly available source material, then indexed by generic drug name, manufacturer, NDC, and package details for faster browsing.
Common brands and presentations in this family
These exact presentation links are useful for brand-name, size, and NDC-specific searches related to this shortage family.
Budesonide 0.5 mg / 2mL Suspension 2 mL - NDC 00093-6816-55Teva Pharmaceuticals USA, Inc. | 30 PouchBudesonide 0.5 mg / 2mL Suspension 2 mL - NDC 00093-6816-73Teva Pharmaceuticals USA, Inc. | 6 PouchBudesonide 0.5 mg / 2mL Suspension 2 mL (Pulmicort Respules) - NDC 00186-1989-04AstraZeneca Pharmaceuticals LP | 6 PouchBudesonide 0.25 mg / 2mL Inhalant 2 mL - NDC 00487-9601-01Nephron Pharmaceuticals Corporation | 6 PouchBudesonide 0.25 mg / 2mL Inhalant 2 mL - NDC 00487-9601-30Nephron Pharmaceuticals Corporation | 30 Pouch
Exact NDC product pages in this shortage family
Use the exact NDC page when your team needs package-level product details, public shortage references, and the strongest route into RFQ and sourcing workflows. These links open directly to the Drug Shortage Information section for each product page.
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.